S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK -7.14%
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stenocare A/S
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Operating Expenses
-kr19.7m
CAGR 3-Years
-17%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Operating Expenses
-kr110.7B
CAGR 3-Years
-26%
CAGR 5-Years
-18%
CAGR 10-Years
-11%
H Lundbeck A/S
CSE:HLUN A
Operating Expenses
-kr12.1B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Operating Expenses
-kr2.4B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Operating Expenses?
Operating Expenses
-19.7m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Operating Expenses amounts to -19.7m DKK.

What is Stenocare A/S's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-21%

Over the last year, the Operating Expenses growth was 6%. The average annual Operating Expenses growth rates for Stenocare A/S have been -17% over the past three years , -21% over the past five years .

Back to Top